UCF-101 mitigates streptozotocin-induced cardiomyocyte dysfunction: role of AMPK
Authors:
- 1 October 2009
- journal article
- retracted article
- Published by American Physiological Society in American Journal of Physiology-Endocrinology and Metabolism
- Vol. 297 (4) , E965-E973
Abstract
Diabetic heart disease contributes to the high mortality in diabetics, although effective clinical management is lacking. The protease inhibitor 5-[5-(2-nitrophenyl) furfuryliodine]-1,3-diphenyl-2-thiobarbituric acid (UCF-101) was reported to protect the hearts against ischemic injury. This study examined the role of UCF-101 on streptozotocin (STZ)-induced diabetic heart defect. Vehicle or UCF-101 was administrated to STZ diabetic mice, and cardiomyocyte mechanical properties were analyzed. UCF-101 reduced STZ-induced hyperglycemia and alleviated STZ-induced aberration in cardiomyocyte contractile mechanics. Diabetes dramatically decreased AMPK phosphorylation at Thr172 of catalytic α-subunit, which was restored by UCF-101. Neither diabetes nor UCF-101 affected the expression of HtrA2/Omi and XIAP or caspase-3 activity. The AMPK activator resveratrol mimicked the UCF-101-induced beneficial effect against diabetic cardiac dysfunction. Mechanical properties in cardiomyocytes from the AMPK-kinase-dead (KD) mice displayed markedly impaired contractile function reminiscent of diabetes. STZ injection in AMPK-KD mice failed to elicit any additional cardiomyocyte contractile defect. UCF-101 significantly downregulated the AMPK-degrading enzymes PP2A and PP2C, the effect of which was mimicked by resveratrol. Taken together, these results indicate that UCF-101 protects against STZ-induced cardiac dysfunction, possibly through AMPK signaling.Keywords
This publication has 35 references indexed in Scilit:
- Retracted: The protease inhibitor UCF‐101 ameliorates streptozotocin‐induced mouse cardiomyocyte contractile dysfunction in vitro: role of AMP‐activated protein kinaseExperimental Physiology, 2009
- Resveratrol Inhibits Cardiac Hypertrophy via AMP-activated Protein Kinase and AktJournal of Biological Chemistry, 2008
- Effect of a Multifactorial Intervention on Mortality in Type 2 DiabetesNew England Journal of Medicine, 2008
- Resveratrol enhances GLUT‐4 translocation to the caveolar lipid raft fractions through AMPK/Akt/eNOS signalling pathway in diabetic myocardiumJournal of Cellular and Molecular Medicine, 2008
- New Drugs for the Treatment of Diabetes MellitusCirculation, 2008
- The serine protease Omi/HtrA2 is involved in XIAP cleavage and in neuronal cell death following focal cerebral ischemia/reperfusionNeurochemistry International, 2007
- Role of AMP-activated protein kinase in healthy and diseased heartsAmerican Journal of Physiology-Heart and Circulatory Physiology, 2006
- Role of Omi/HtrA2 in Apoptotic Cell Death After Myocardial Ischemia and ReperfusionCirculation, 2005
- Characterization of a Novel and Specific Inhibitor for the Pro-apoptotic Protease Omi/HtrA2Journal of Biological Chemistry, 2003
- A rapid and sensitive method for the quantitation of microgram quantities of protein utilizing the principle of protein-dye bindingAnalytical Biochemistry, 1976